Singapore news brief
India orders top drugmaker to halt eye medicine production at plant over quality lapses
NEWS DESKSingapore
PUBLISHEDOct 30, 2026, 12:55 PM
What the source reports
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.
Main source: Channel News Asia
TDBN presents the written preview supplied through the publisher's feed. Complete reporting, continuing updates, context, and corrections remain with the original report.
Read the complete report ↗